Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose-Reference-Cited by-同舟云学术

Real-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin Dose

Published:2020-11-15 Issue:6 Volume:14 Page:775-782
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Jang Eun Sun¹^ORCID,Kim Kyung-Ah²^ORCID,Kim Young Seok³^ORCID,Kim In Hee⁴^ORCID,Lee Byung Seok^ORCID,Lee Youn Jae⁵^ORCID,Chung Woo Jin⁶^ORCID,Jeong Sook-Hyang¹^ORCID

Affiliation:

1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea

2. Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea

3. Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea

4. Department of Internal Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea

5. Department of Internal Medicine, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea

6. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea

Funder

Gilead Foundation

Korea Centers for Disease Control and Prevention

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2020/014/GNL014-06-11.pdf

Reference31 articles.

1. Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence

2. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013

3. A nationwide seroepidemiology of hepatitis C virus infection in South Korea

4. Type and cause of liver disease in Korea: single-center experience, 2005-2010

5. Clinical and epidemiological features of hepatitis C virus infection in South Korea: A prospective, multicenter cohort study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognosis Following Sustained Virologic Response in Korean Chronic Hepatitis C Patients Treated with Sofosbuvir-Based Treatment: Data from a Multicenter Prospective Observational Study up to 7 Years;Medicina;2024-07-14

2. Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea;Clinical and Molecular Hepatology;2023-04-01

3. National Brazilian survey on the outcomes of hepatitis c retreatment in patients non-responders to direct antiviral agents;The Brazilian Journal of Infectious Diseases;2022-07

4. Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients;The Eurasian Journal of Medicine;2022-06-03

5. A cost-effectiveness study of universal screening for hepatitis C virus infection in South Korea: A societal perspective;Clinical and Molecular Hepatology;2022-01-01